9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia

      letter

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Candida auris is an emerging multidrug-resistant fungus that causes a wide range of symptoms. We report finding 17 cases of C. auris infection that were originally misclassified but correctly identified 27.5 days later on average. Patients with a delayed diagnosis of C. auris had a 30-day mortality rate of 35.2%.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: found
          • Article: not found

          Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital.

          A single strain of a novel ascomycetous yeast species belonging to the genus Candida was isolated from the external ear canal of an inpatient in a Japanese hospital. Analyses of the 26S rDNA D1/D2 domain, nuclear ribosomal DNA ITS region sequences, and chemotaxonomic studies indicated that this strain represents a new species with a close phylogenetic relationship to Candida ruelliae and Candida haemulonii in the Metschnikowiaceae clade. This strain grew well at 40 degrees C, but showed slow and weak growth at 42 degrees C. The taxonomic description of Candida auris sp. nov. is proposed (type strain JCM15448T= CBS10913T= DSM21092T).
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.

            Characterization of a hospital outbreak of Candida auris candidemia that involved 18 critically ill patients in Venezuela.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Candida auris–Associated Candidemia, South Africa

              To the Editor: We noted the report by Chowdhary et al. ( 1 ) and report Candida auris as a causative agent of candidemia in South Africa, with an estimated prevalence of 0.3% (N.P. Govender et al., unpub. data). First isolated in 2009, C. auris is an emerging species associated with clinical disease ( 2 – 6 ). We analyzed 4 isolates submitted to the National Institute for Communicable Diseases (Johannesburg, South Africa) from 4 patients with candidemia who had been admitted to different public- and private-sector hospitals from October 2012 through October 2013. Identification of the isolates was undertaken by using ChromAgar Candida medium (Mast Diagnostics, Merseyside, UK), Vitek-2 YST (bioMérieux, Marcy ľEtoile, France), API 20C AUX (bioMérieux), and sequencing of internal transcribed spacer (ITS) and D1/D2 domains of the ribosomal RNA gene ( 7 ), followed by microbroth dilution susceptibility testing ( 8 ). All isolates were misidentified as C. haemulonii and Rhodotorula glutinis by Vitek-2 YST and API 20C AUX assays, respectively (Table). Table Identification and antifungal susceptibility results of 4 Candida auris isolates from 4 male patients with candidemia, South Africa, October 2012–October 2013* Isolate ID Patient age, y Hospital unit Vitek-2 YST† API 20C AUX† DNA sequence analysis‡ MIC AMB FLX VRC POS ITC 5FC CAS MFG AFG 208 85 High-care C. haemulonii Rhodotorula glutinis C. auris 1 >256 0.5 0.03 0.12 0.12 0.25 0.06 0.25 209 60 Medical ICU C. haemulonii R. glutinis C. auris 0.5 >256 1 0.06 0.12 0.12 0.12 0.06 0.12 224 73 Burn C. haemulonii R. glutinis C. auris 1 >256 2 0.06 0.25 0.12 0.25 0.12 0.25 293 27 Trauma ICU C. haemulonii R. glutinis C. auris 1 64 0.25 0.015 0.06 0.06 0.03 0.06 0.06 *AMB, amphotericin B; FLX, fluconazole; VRC, voriconazole; POS, posaconazole; ITC, itraconazole; 5FC, flucytosine; CAS, caspofungin; MFG, micafungin; AFG, anidulafungin.
†bioMérieux, Marcy ľEtoile, France.
‡Sequence data for the 4 isolates have been deposited in GenBank, accession nos. KJ1236762–KJ126765 and KJ126758–KJ126761 for the internal transcribed spacer and D1/D2 regions, respectively. Similar to the findings of Chowdhary et al., all isolates assimilated N-acetyl-glucosamine ( 1 ). With the use of the CBS-KNAW database, pairwise sequence alignment of ITS region showed 99% sequence homology to Kuwait isolates, and alignment of D1/D2 domain showed 98% homology to the Kuwait/India isolates ( 9 ). In a neighbor-joining phylogenetic tree based on ITS sequences, South Africa isolates formed a cluster with India and Kuwait isolates (Technical Appendix Figure). Fluconazole MICs were high for all isolates (Table). Isolates 209 and 224 showed reduced voriconazole susceptibility with MICs of 1 μg/mL and 2 μg/mL, respectively, which is above the epidemiologic cutoff value for 11 Candida species ( 10 ). Isolates were susceptible to amphotericin B and echinocandins at low MICs Clinical data were available for 1 patient (Technical Appendix Table). Two C. haemulonii isolates were identified during laboratory-based sentinel surveillance for candidemia in South Africa; the ITS region of one isolate was sequenced and the isolate identified as C. auris (N.P. Govender, pers. comm.). In this study, C. auris was misidentified by routinely used tests and was accurately identified by sequencing, in keeping with previous findings ( 1 , 3 , 4 , 6 ). Technical Appendix Phylogenetic relatedness of internal transcribed spacer region of the ribosomal RNA gene of Candida auris with closely related Candida species and clinical characteristics of a patient with candidemia caused by C. auris, South Africa.
                Bookmark

                Author and article information

                Journal
                Emerg Infect Dis
                Emerging Infect. Dis
                EID
                Emerging Infectious Diseases
                Centers for Disease Control and Prevention
                1080-6040
                1080-6059
                January 2017
                : 23
                : 1
                : 162-164
                Affiliations
                [1]Universidad Popular del Cesar, Valledupar, Colombia (S.E. Morales-López, H.P. Martínez);
                [2]Pontificia Universidad Javeriana, Bogotá, Colombia (C.M. Parra-Giraldo, A. Ceballos-Garzón);
                [3]Centro de Investigaciones Microbiológicas del Cesar (CIMCE), Valledupar, Colombia (G.J. Rodríguez, J.Y. Rodríguez);
                [4]Clínica Laura Daniela, Valledupar (G.J. Rodríguez, J.Y. Rodríguez);
                [5]Universidad Nacional de Colombia, Bogotá (C.A. Álvarez-Moreno);
                [6]Clínica Universitaria Colombia, Colsanitas, Colombia (C.A. Álvarez-Moreno)
                Author notes
                Address for correspondence: José Y. Rodríguez, Centro de Investigaciones, Microbiológicas del Cesar (CIMCE), Calle 16c no 19d-14 Barrio Dangond, Valledupar, Colombia; email: jyrodriguezq@ 123456gmail.com
                Article
                16-1497
                10.3201/eid2301.161497
                5176232
                27983941
                a4f1a3ec-0b37-4881-9a79-4e59192a67cd
                History
                Categories
                Letters to the Editor
                Letter
                Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia

                Infectious disease & Microbiology
                candida auris,americas,antimicrobial resistance,candidemia,vitek,etest,colombia,fungemia,fungi

                Comments

                Comment on this article